Picture of IDEXX Laboratories logo

IDXX — IDEXX Laboratories News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareBalancedLarge CapHigh Flyer

Idexx Laboratories Inc Reports Results For The Quarter Ended March 31: Earnings Summary

IDEXX Laboratories Inc IDXX.OQ reported quarterly adjusted earnings of $2.96​​ per share for the quarter ended March 31, higher than the same quarter last year, when the company reported EPS of $2.81.  The mean expectation of ten analysts for the quarter was for earnings of $2.85 per share. Wall Street expected results to range from $2.77  to $2.95 per share.

Revenue rose 3.6% to $998.43 million from a year ago; analysts expected $998.15 million.

IDEXX Laboratories Inc's reported EPS for the quarter was $2.96​.

The company reported quarterly net income of $242.68 million.

IDEXX Laboratories Inc shares had risen by 3.0% this quarter and gained 4.6% so far this year.

FORECAST CHANGES

The mean earnings estimate of analysts had fallen by about 4.5% in the last three months.​

In the last 30 days, three analysts negatively revised earnings estimates

RECOMMENDATIONS

The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 8 "strong buy" or "buy," 6 "hold" and no "sell" or "strong sell." The average consensus recommendation for the medical equipment, supplies & distribution peer group is also "buy"

Wall Street's median 12-month price target for IDEXX Laboratories Inc is $517.50

This summary was machine generated from LSEG data May 1 at 01:31 p.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)

QUARTER ENDINGESTIMATEACTUALBEAT, MET, MISSED
Mar. 31 20252.852.96Beat
Dec. 31 20242.402.62Beat
Sep. 30 20242.682.80Beat
Jun. 30 20242.883.02Beat

Recent news on IDEXX Laboratories

See all news